nodes	percent_of_prediction	percent_of_DWPC	metapath
Tafluprost—PTGS2—melanoma	0.692	1	CbGaD
Tafluprost—PTGFR—ciliary body—melanoma	0.126	0.709	CbGeAlD
Tafluprost—PTGS2—leg—melanoma	0.00833	0.0467	CbGeAlD
Tafluprost—PTGS2—hindlimb—melanoma	0.00743	0.0417	CbGeAlD
Tafluprost—PTGFR—eye—melanoma	0.00687	0.0386	CbGeAlD
Tafluprost—PTGS2—appendage—melanoma	0.00638	0.0358	CbGeAlD
Tafluprost—PTGS2—skin epidermis—melanoma	0.00531	0.0298	CbGeAlD
Tafluprost—PTGFR—head—melanoma	0.0039	0.0219	CbGeAlD
Tafluprost—PTGS2—endothelium—melanoma	0.00385	0.0216	CbGeAlD
Tafluprost—PTGS2—blood vessel—melanoma	0.00355	0.0199	CbGeAlD
Tafluprost—PTGFR—lymph node—melanoma	0.00273	0.0153	CbGeAlD
Tafluprost—PTGS2—skin of body—melanoma	0.00164	0.00922	CbGeAlD
Tafluprost—PTGS2—head—melanoma	0.00107	0.00602	CbGeAlD
Tafluprost—PTGS2—lymph node—melanoma	0.000751	0.00421	CbGeAlD
Tafluprost—PTGS2—Metabolism—UGT2B10—melanoma	0.000125	0.00097	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.000124	0.000958	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—EDN1—melanoma	0.000123	0.000955	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CXCL8—melanoma	0.000122	0.00094	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CSF2—melanoma	0.000121	0.000933	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—melanoma	0.00012	0.000927	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	0.000119	0.000923	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—MYC—melanoma	0.000119	0.000922	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CDKN1B—melanoma	0.000119	0.000918	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—RAC1—melanoma	0.000118	0.000913	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—HS3ST5—melanoma	0.000117	0.000902	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CASP3—melanoma	0.000116	0.0009	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IL2—melanoma	0.000116	0.000899	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PRKCA—melanoma	0.000116	0.000895	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CCND1—melanoma	0.000113	0.000876	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—MAP2K2—melanoma	0.000113	0.000875	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—APC—melanoma	0.000112	0.000869	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—melanoma	0.000111	0.000859	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—F2R—melanoma	0.000111	0.000856	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—KRAS—melanoma	0.00011	0.000852	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—MMP9—melanoma	0.00011	0.000851	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—RAC1—melanoma	0.000107	0.00083	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—EDNRB—melanoma	0.000107	0.000829	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—TNF—melanoma	0.000107	0.000828	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	0.000105	0.000809	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PTK2B—melanoma	0.000104	0.000804	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	0.000103	0.000795	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—GNA11—melanoma	0.000101	0.000783	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—GAB2—melanoma	0.000101	0.000783	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FLT1—melanoma	0.000101	0.000779	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PIK3CG—melanoma	9.98e-05	0.000772	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	9.94e-05	0.000769	CbGpPWpGaD
Tafluprost—PTGS2—Disease—TRRAP—melanoma	9.92e-05	0.000768	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CUL3—melanoma	9.92e-05	0.000768	CbGpPWpGaD
Tafluprost—PTGS2—Disease—AKR1B10—melanoma	9.65e-05	0.000747	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CXCR4—melanoma	9.51e-05	0.000736	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HDAC2—melanoma	9.51e-05	0.000736	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FOXO4—melanoma	9.51e-05	0.000736	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	9.45e-05	0.000731	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—GNAQ—melanoma	9.4e-05	0.000727	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	9.39e-05	0.000726	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—HRAS—melanoma	9.36e-05	0.000724	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—MAPK3—melanoma	9.34e-05	0.000723	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—MYC—melanoma	9.08e-05	0.000703	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3CG—melanoma	9.06e-05	0.000701	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	8.98e-05	0.000694	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—MAPK1—melanoma	8.89e-05	0.000688	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—EGFR—melanoma	8.89e-05	0.000687	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	8.84e-05	0.000684	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SYK—melanoma	8.84e-05	0.000684	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PLCB4—melanoma	8.84e-05	0.000684	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PIK3CD—melanoma	8.77e-05	0.000678	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	8.72e-05	0.000675	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ITGAV—melanoma	8.68e-05	0.000671	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—AKT3—melanoma	8.68e-05	0.000671	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NGFR—melanoma	8.68e-05	0.000671	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—FASN—melanoma	8.67e-05	0.000671	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—IL6—melanoma	8.63e-05	0.000668	CbGpPWpGaD
Tafluprost—PTGS2—Disease—LUM—melanoma	8.6e-05	0.000666	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TNF—melanoma	8.46e-05	0.000655	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HPSE—melanoma	8.44e-05	0.000653	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIP4K2A—melanoma	8.31e-05	0.000643	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SLC6A11—melanoma	8.31e-05	0.000643	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CUBN—melanoma	8.28e-05	0.000641	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—MTAP—melanoma	8.08e-05	0.000625	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	8.08e-05	0.000625	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SOCS1—melanoma	8.04e-05	0.000622	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—MAP2K1—melanoma	8.02e-05	0.00062	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—S100B—melanoma	8.02e-05	0.00062	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CSPG4—melanoma	8e-05	0.000619	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3CD—melanoma	7.96e-05	0.000616	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	7.91e-05	0.000612	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	7.9e-05	0.000611	CbGpPWpGaD
Tafluprost—PTGS2—Disease—RPS3—melanoma	7.87e-05	0.000609	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SKI—melanoma	7.75e-05	0.000599	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	7.7e-05	0.000596	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ERBB4—melanoma	7.67e-05	0.000593	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PIK3CB—melanoma	7.64e-05	0.000591	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	7.63e-05	0.00059	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CDKN2B—melanoma	7.6e-05	0.000588	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TP53—melanoma	7.46e-05	0.000577	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	7.45e-05	0.000577	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	7.44e-05	0.000575	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	7.4e-05	0.000573	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CD86—melanoma	7.35e-05	0.000569	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CXCL8—melanoma	7.35e-05	0.000568	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—EDN1—melanoma	7.29e-05	0.000564	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PHGDH—melanoma	7.2e-05	0.000557	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—LUM—melanoma	7.2e-05	0.000557	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CSF2—melanoma	7.13e-05	0.000551	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FGF1—melanoma	7.13e-05	0.000551	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—HPSE—melanoma	7.07e-05	0.000547	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—IL2—melanoma	7.02e-05	0.000543	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—E2F1—melanoma	6.97e-05	0.00054	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3CB—melanoma	6.94e-05	0.000537	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CUBN—melanoma	6.93e-05	0.000536	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PDGFRA—melanoma	6.9e-05	0.000534	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ITGB3—melanoma	6.83e-05	0.000529	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PRKCA—melanoma	6.83e-05	0.000529	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IL6—melanoma	6.83e-05	0.000528	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	6.72e-05	0.00052	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SPP1—melanoma	6.7e-05	0.000518	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SDHD—melanoma	6.7e-05	0.000518	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—BSG—melanoma	6.7e-05	0.000518	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CSPG4—melanoma	6.7e-05	0.000518	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MAP2K2—melanoma	6.68e-05	0.000517	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CXCL8—melanoma	6.67e-05	0.000516	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GPAM—melanoma	6.49e-05	0.000502	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HDAC6—melanoma	6.39e-05	0.000495	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL2—melanoma	6.38e-05	0.000493	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	6.35e-05	0.000492	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TERT—melanoma	6.35e-05	0.000491	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—RAC1—melanoma	6.33e-05	0.00049	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—melanoma	6.18e-05	0.000478	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HIF1A—melanoma	6.07e-05	0.00047	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NPPA—melanoma	6.06e-05	0.000469	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	6.05e-05	0.000468	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	6.04e-05	0.000468	CbGpPWpGaD
Tafluprost—PTGS2—Disease—VCAN—melanoma	5.92e-05	0.000458	CbGpPWpGaD
Tafluprost—PTGS2—Disease—WNT5A—melanoma	5.87e-05	0.000454	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—KDR—melanoma	5.81e-05	0.000449	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—melanoma	5.76e-05	0.000445	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	5.71e-05	0.000442	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FN1—melanoma	5.59e-05	0.000433	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PLA2G6—melanoma	5.52e-05	0.000427	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NOTCH1—melanoma	5.47e-05	0.000423	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CD80—melanoma	5.36e-05	0.000415	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—KIT—melanoma	5.35e-05	0.000414	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—APC—melanoma	5.35e-05	0.000414	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3CG—melanoma	5.35e-05	0.000414	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—NRAS—melanoma	5.35e-05	0.000414	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—EGF—melanoma	5.29e-05	0.000409	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	5.25e-05	0.000406	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—MAPK3—melanoma	5.13e-05	0.000397	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—melanoma	5.07e-05	0.000393	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—BRAF—melanoma	5.03e-05	0.000389	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—VCAN—melanoma	4.95e-05	0.000383	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IGF1—melanoma	4.9e-05	0.000379	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—MAPK1—melanoma	4.88e-05	0.000377	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—EGFR—melanoma	4.88e-05	0.000377	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MAP2K1—melanoma	4.74e-05	0.000366	CbGpPWpGaD
Tafluprost—PTGS2—Disease—GAB2—melanoma	4.71e-05	0.000365	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3CD—melanoma	4.7e-05	0.000364	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	4.69e-05	0.000363	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PIK3CA—melanoma	4.66e-05	0.000361	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FASN—melanoma	4.61e-05	0.000357	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—KRAS—melanoma	4.61e-05	0.000356	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.53e-05	0.00035	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FGF2—melanoma	4.5e-05	0.000348	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FOXO4—melanoma	4.43e-05	0.000343	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CXCR4—melanoma	4.43e-05	0.000343	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HDAC2—melanoma	4.43e-05	0.000343	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CD44—melanoma	4.38e-05	0.000339	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	4.29e-05	0.000332	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3CA—melanoma	4.23e-05	0.000327	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MDM2—melanoma	4.21e-05	0.000326	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYP17A1—melanoma	4.18e-05	0.000323	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ERBB2—melanoma	4.16e-05	0.000321	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.12e-05	0.000319	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3CB—melanoma	4.1e-05	0.000317	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—ALB—melanoma	4.07e-05	0.000315	CbGpPWpGaD
Tafluprost—PTGS2—Disease—AKT3—melanoma	4.04e-05	0.000313	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GNA11—melanoma	3.95e-05	0.000305	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CXCL8—melanoma	3.94e-05	0.000305	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—HRAS—melanoma	3.92e-05	0.000303	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—FASN—melanoma	3.86e-05	0.000299	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CDKN1B—melanoma	3.85e-05	0.000298	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—AKT1—melanoma	3.81e-05	0.000295	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SLC5A5—melanoma	3.8e-05	0.000294	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CASP3—melanoma	3.77e-05	0.000292	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL2—melanoma	3.77e-05	0.000291	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL6—melanoma	3.75e-05	0.00029	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCND1—melanoma	3.67e-05	0.000284	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GNAQ—melanoma	3.67e-05	0.000284	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CD44—melanoma	3.67e-05	0.000284	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CTNNB1—melanoma	3.64e-05	0.000281	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.59e-05	0.000278	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ERBB4—melanoma	3.57e-05	0.000276	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MMP9—melanoma	3.56e-05	0.000276	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CDKN1A—melanoma	3.55e-05	0.000275	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PTEN—melanoma	3.54e-05	0.000274	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CDKN2B—melanoma	3.54e-05	0.000274	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NFKB1—melanoma	3.53e-05	0.000273	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYP1B1—melanoma	3.52e-05	0.000272	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—AKT1—melanoma	3.46e-05	0.000267	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CD86—melanoma	3.42e-05	0.000265	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FGF1—melanoma	3.32e-05	0.000257	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PDGFRA—melanoma	3.22e-05	0.000249	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—VEGFA—melanoma	3.2e-05	0.000248	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PRKCA—melanoma	3.18e-05	0.000246	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—STAT3—melanoma	3.17e-05	0.000245	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NRAS—melanoma	3.16e-05	0.000245	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ERCC2—melanoma	3.16e-05	0.000244	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MAP2K2—melanoma	3.11e-05	0.000241	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.11e-05	0.00024	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MAPK3—melanoma	3.03e-05	0.000234	CbGpPWpGaD
Tafluprost—PTGS2—Disease—TERT—melanoma	2.96e-05	0.000229	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HLA-A—melanoma	2.96e-05	0.000229	CbGpPWpGaD
Tafluprost—PTGS2—Disease—RAC1—melanoma	2.95e-05	0.000228	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MYC—melanoma	2.94e-05	0.000228	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ABCB1—melanoma	2.9e-05	0.000224	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MAPK1—melanoma	2.88e-05	0.000223	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—EGFR—melanoma	2.88e-05	0.000223	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HIF1A—melanoma	2.83e-05	0.000219	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—KRAS—melanoma	2.72e-05	0.00021	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PRKCA—melanoma	2.67e-05	0.000206	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ERCC2—melanoma	2.64e-05	0.000205	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NOS2—melanoma	2.57e-05	0.000199	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NOTCH1—melanoma	2.55e-05	0.000197	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3CA—melanoma	2.5e-05	0.000193	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CD80—melanoma	2.5e-05	0.000193	CbGpPWpGaD
Tafluprost—PTGS2—Disease—APC—melanoma	2.49e-05	0.000193	CbGpPWpGaD
Tafluprost—PTGS2—Disease—KIT—melanoma	2.49e-05	0.000193	CbGpPWpGaD
Tafluprost—PTGS2—Disease—EGF—melanoma	2.47e-05	0.000191	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TP53—melanoma	2.42e-05	0.000187	CbGpPWpGaD
Tafluprost—PTGS2—Disease—BRAF—melanoma	2.34e-05	0.000181	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HRAS—melanoma	2.31e-05	0.000179	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL6—melanoma	2.21e-05	0.000171	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MAP2K1—melanoma	2.21e-05	0.000171	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PIK3CD—melanoma	2.19e-05	0.00017	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.19e-05	0.000169	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FGF2—melanoma	2.1e-05	0.000162	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3CG—melanoma	2.09e-05	0.000162	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—AKT1—melanoma	2.04e-05	0.000158	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PPARG—melanoma	2.02e-05	0.000156	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MDM2—melanoma	1.96e-05	0.000152	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ERBB2—melanoma	1.94e-05	0.00015	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PIK3CB—melanoma	1.91e-05	0.000148	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CD4—melanoma	1.91e-05	0.000148	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3CD—melanoma	1.84e-05	0.000142	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ALB—melanoma	1.81e-05	0.00014	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CDKN1B—melanoma	1.79e-05	0.000139	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CTNNB1—melanoma	1.69e-05	0.000131	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CDKN1A—melanoma	1.65e-05	0.000128	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PTEN—melanoma	1.65e-05	0.000128	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3CB—melanoma	1.6e-05	0.000124	CbGpPWpGaD
Tafluprost—PTGS2—Disease—STAT3—melanoma	1.48e-05	0.000114	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NRAS—melanoma	1.47e-05	0.000114	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MAPK3—melanoma	1.41e-05	0.000109	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PTEN—melanoma	1.38e-05	0.000107	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MYC—melanoma	1.37e-05	0.000106	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MAPK1—melanoma	1.34e-05	0.000104	CbGpPWpGaD
Tafluprost—PTGS2—Disease—EGFR—melanoma	1.34e-05	0.000104	CbGpPWpGaD
Tafluprost—PTGS2—Disease—KRAS—melanoma	1.27e-05	9.81e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PIK3CA—melanoma	1.16e-05	9.01e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HRAS—melanoma	1.08e-05	8.34e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IL6—melanoma	1.03e-05	7.98e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3CA—melanoma	9.76e-06	7.55e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—AKT1—melanoma	9.52e-06	7.36e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—AKT1—melanoma	7.97e-06	6.17e-05	CbGpPWpGaD
